+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors associated with statin selection among privately insured commercial and Medicare patients



Factors associated with statin selection among privately insured commercial and Medicare patients



Current Medical Research and Opinion 29(4): 395-404



Given the availability of several statins in the United States, it is important to understand patient characteristics associated with their initiation. We analyzed demographic and clinical factors associated with statin selection among new statin users. This retrospective cohort study examined factors associated with statin selection among patients newly initiated on therapy between 1/1/2007 and 12/31/2007. Commercial and Medicare patient cohorts were evaluated separately and comparisons were made between pravastatin (PS) and other statins including simvastatin (SS), atorvastatin (AS), or rosuvastatin (RS). Multiple logistic regression models were employed to assess factors associated with PS initiation versus other statins. In commercially insured patients, patients initiating PS were more likely to be older, female, and have diabetes mellitus, liver dysfunction, human immunodeficiency virus (HIV) infection, or hypertension and use calcium channel blockers, protease inhibitors, or additional lipid-modifying agents (p < 0.01 for each comparison). In Medicare-age patients, a higher percentage of PS initiators were aged 75-85, female, had atrial fibrillation, and were prescribed warfarin or triazole antifungals (p < 0.01 for each comparison). Presence of atrial fibrillation or HIV infection, or use of calcium channel blockers or additional lipid-modifying agents was associated with PS initiation compared with AS and SS. Use of warfarin was significantly associated with initiating PS compared with SS, AS, and RS in Medicare-age patients. Older age and female gender were associated with PS initiation. In addition, selected comorbidities and use of certain medications including warfarin or protease inhibitors were associated with PS initiation, which may reflect the tolerability of PS and its reduced risk of significant drug-drug interactions for certain patients. Because this study is a retrospective analysis of US healthcare claims, the findings are limited to only those factors captured within claims data and may not be generalizable to all patient populations in which statin therapy is initiated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053194629

Download citation: RISBibTeXText

PMID: 23406054

DOI: 10.1185/03007995.2013.776525


Related references

Medicare and privately insured patients are likely to pay more than others for similar home health services. Home Healthcare Nurse 16(7): 483-484, 1998

Study finds improvements in cancer survival for privately insured and medicare patients, but not others. Cancer 124(10): 2071-2071, 2018

Differences in the structure of CAHPS measures among the medicare fee-for-service, medicare managed care, and privately insured populations. Health Services Research 36(3): 489-508, 2001

Increasing Trends in the Use of Hospital Observation Services for Older Medicare Advantage and Privately Insured Patients. Medical Care Research and Review 1077558717718026-1077558717718026, 2017

Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthalmology 124(3): 352-358, 2016

Physician responses to rising local unemployment rates: Healthcare provision to Medicare and privately insured patients. Journal of Health Economics 40: 97-108, 2015

Utilization and Costs of Postoperative Physical Therapy After Rotator Cuff Repair: A Comparison of Privately Insured and Medicare Patients. Arthroscopy 31(12): 2392-9.E1, 2016

Explaining source of payment differences in U.S. cesarean rates: why do privately insured mothers receive more cesareans than mothers who are not privately insured?. Health Care Management Science 8(1): 5-17, 2005

Variations in hospital resource use for Medicare and privately insured populations in California. Health Affairs 27(2): W123-W134, 2008

Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis. Journal of Managed Care & Specialty Pharmacy 22(8): 969-978, 2016

Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women. American Journal of Obstetrics and Gynecology 215(4): 447.E1-447.E13, 2017

The struggle for rural pharmacies: will Medicare's new privately insured prescription drug covera ge jeopardize valuable pharmacy services for rural seniors?. Journal of Contemporary Health Law and Policy 21(1): 99-136, 2005

Datapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children. Psychiatric Services 53(12): 1508-1508, 2002

Are publicly insured children less likely to be admitted to hospital than the privately insured (and does it matter)?. Economics and Human Biology 25: 33-51, 2017

Comprehension of quality care indicators: differences among privately insured, publicly insured, and uninsured. Health Care Financing Review 18(1): 75-94, 1997